Bharat Biotech vaccine 2nd phase trial in GMCH

August 15, 2020: Hope for the people of Assam. The 2nd phase trial of the Covid-19 vaccine by Bharat Biotech will be conducted at Guwahati Medical College Hospital.

DY365
DY365
Bharat Biotech vaccine 2nd phase trial in GMCH

August 15, 2020: Hope for the people of Assam. The 2nd phase trial of the Covid-19 vaccine by Bharat Biotech will be conducted at Guwahati Medical College Hospital.

The Bharat Biotech and the ICMR have chosen GMCH as one of the centres for the second phase trial of the COVAXIN. The trial is most likely to begin next month. This was informed by Assam health minister Dr Himanta Biswa Sharma on Friday.

Preliminary results of Phase 1 clinical trials showed that Covaxin is safe. The findings of phase 1 trials will be submitted soon.

At present trials are on for the vaccine with 375 volunteers across 12 sites in the country. Each volunteer has been administered two doses of the vaccine.

Bharat Biotech and ICMR developed COVAXIN which is India’s first indigenous vaccine against COVID-19.

COVAXIN is derived from a strain of the SARS-CoV-2 virus isolated in NIV, Pune, and transferred to Bharat Biotech to develop into a vaccine candidate.

Related Links